Animal in vivo models of EBV-associated lymphoproliferative diseases: Special references to rabbit models

Histology and Histopathology

Volumn 17, Issue 4, 2002, Pages 1293-1310

  Hayashi, Kazuhiko ^a   Teramoto, N ^a   Akagi, T ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Animal model; EBV; LPD; Lymphocryptovirus; Rabbit

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN G; VIRUS DNA;

BLEEDING DISORDER; CARCINOGENESIS; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; DISEASE CONTROL; EPSTEIN BARR VIRUS; EXPERIMENTAL MODEL; GENE THERAPY; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HERPES VIRUS; HUMAN; IN VIVO STUDY; INOCULATION; LYMPHOMA CELL; LYMPHOPROLIFERATIVE DISEASE; MONKEY; NONHUMAN; NUDE MOUSE; PATHOGENESIS; PERIPHERAL CIRCULATION; POLYMERASE CHAIN REACTION; RABBIT; REVIEW; SEROCONVERSION; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HAPLORHINI; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, SCID; RABBITS;

ANIMALIA; DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS PAPIO; HUMAN HERPESVIRUS 4; LYMPHOCRYPTOVIRUS; MUS MUSCULUS; ORYCTOLAGUS CUNICULUS; PAPIO; SIMIAE;

EID: 0036792223     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Ambinder R.F. (2000). Gammaherpesviruses and "Hit-and-Run" oncogenesis. Am. J. Pathol. 156, 1-3.
2. Anagnostopoulos I, Hummel M. (2000). Epstein-Barr virus in tumours. Histopathology 29, 297-315.
3. Bach F.H., Fishman J.A., Daniels N., Proimos J., Anderson B., Carpenter C.B., Forrow L., Robson S.C. and Fineberg H.V. (1998). Uncertainty in xenotransplantation: Individual benefit versus collective risk. Nature Med. 4, 141-144.
4. Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C., Tuffnell P.S. and Barrell B.G. (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211.
5. Barnes A., Dyson H., Sunil-Chandra N.P., Collins P. and Nash A.A. (1999). 2′-Deoxy-5-ethyl-beta-4′-thiouridine inhibits replication of murine gammaherpesvirus and delays the onset of virus latency. Antivir. Chem. Chemother. 10, 321-326.
6. Blaskovic D., Stancekova M., Svobodova J. and Mistrikova J. (1980). Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol. 24, 468.
7. Buchsbaum R.J., Fabry J.A. and Lieberman J. (1996). EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice. Immunol. Lett. 52, 145-152.
8. Chang K.L., Chen Y.Y., Shibata D. and Weiss L.M. (1992). Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1, 246-255
9. Chen H-L., Hayashi K., Koirala T.R., Ino H., Fujimoto K., Yoshikawa Y., Choudhury C.R. and Akagi T. (1997). Malignant lymphoma induction in rabbits by oral inoculation of crude virus fraction prepared from Ts-B6 cells (Cynomolgus B-lymphoblastoid cells harboring Epstein-Barr virus-related simian herpesvirus). Acta Med. Okayama 51, 141-147.
10. Chen J.S., Tzeng C.C., Tsao C.J., Su W.C., Chen T.Y., Jung Y.C. and Su I.J. (1997). Clonal karyotype abnormalities in EBV-associated hemophagocytic syndrome. Haematologica 82, 572-576.
11. Cleary M.L., Epstein M.A., Finerty S., Dorfman R.F., Bornkamm G.W., Kirkwood J.K., Morgan A.J. and Sklar J. (1985). Individual tumors of multifocal Epstein-Barr virus-induced malignant lymphomas in Tamarins arise from different B-cell clones. Science 228, 722-724
12. Craig F.E., Clare C.N., Sklar J.L. and Banks P.M. (1992). T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am. J. Clin. Pathol. 97, 189-194.
13. Dillner J., Rabin H., Letvin N., Henle W., Henle G. and Klein G. (1987). Nuclear DNA-binding proteins determined by the Epstein-Barr-virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio. J. Gen. Virol. 68, 1587-1596.
14. Dolezal M.V., Kamel O.W., van de Rijn M., Cleary M.L., Sibley R.K. and Warnke R.A. (1995). Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. Am. J. Clin. Pathol. 103, 189-194.
15. Epstein M.A, Achong B.G. and Barr Y.M. (1964). Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1, 702-703
16. Falk LA. (1979). A review of Herpesvirus papio, a B-lymphotropic virus of baboons related to EBV. Comp. Immun. Microbiol. Infect. Dis. 2, 257-264.
17. Farrell P.J., Hollyoake M., Niedobitek G., Agathanggelou A., Morgan A. and Wedderburn N. (1997). Direct demonstration of persistent Epstein-Barr virus gene expression in peripheral blood of infected common marmosets and analysis of virus-infected tissues in vivo. J. Gen. Virol. 78, 1417-1424.
18. Feichtinger H., Li S.L., Kaaya E.E., Putkonen P., Grunewald K., Weyrer K., Bottinger D., Ernberg I., Linde A., Bieberfeld G. and Bieberfeld P. (1992). A monkey model for Epstein-Barr-virus associated lymphomagenesis in human acquired immunodeficiency syndrome. J. Exp. Med. 176, 281-286.
19. Ferrari M.G., Rivadeneira E.D., Jarrett R., Stevceva L., Takemoto S., Markham P. and Franchini G. (2001). HV(MNE), a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits. Blood 98, 2193-2199.
20. Franken M., Devergne O., Rosenzweig M., Annis B., Kieff E. and Wang F. (1996). Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J. Virol. 70, 7819-7826
21. Fuentes-Panana E.M., Swaminathan S. and Ling P.D. (1999). Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15). J. Virol. 73, 826-833
22. Fujimoto K., Terato K., Miyamoto J., Ishiko H., Fujisaki M., Cho F. and Honjo S. (1990). Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a Cynomolgus monkey (Macaca fascicularis). J. Med. Primatol. 19, 21-30.
23. Gao F., Bailes E., Robertson D.L., Chen Y., Rodenburg C.M., Michael S.F., Cummins L.B., Arthur L.O., Peeters M., Shaw G.M., Sharp P.M. and Hahn B.H. (1999). Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397, 436-441.
24. Habis A., Baskin G.B., Murphey-Corb M. and Levy L.S. (1999). Simian AIDS-associated lymphoma in rhesus and cynomolgus monkeys recapitulates the primary pathobiological features of AIDS-associated non-Hodgkin's lymphoma. AIDS Res. Hum. Retroviruses. 15, 1389-1398.
25. Hayashi K. and Akagi T. (2000). An animal model for Epstein-Barr virus (EBV)-associated lymphomagenesis in the human: Malignant lymphoma induction of rabbits by EBV-related herpesvirus from cynomolgus. Pathol. Int. 50, 85-97.
26. Hayashi K., Ohara N., Fujiwara K., Aoki H., Jeon H.J., Takahashi K., Tomita N., Miyamoto K. and Akagi T. (1993). Co-expression of CD4 and CD8 associated with elevated interleukin-4 in a cord T cell line derived by coculturing normal human cord leukocytes and an HTLV-II-producing simian leukocyte cell line (Si-IIA). J. Cancer Res. Clin. Oncol. 119, 137-141
27. Hayashi K., Ohara N., Koirala T.R., Ino H., Chen H.L., Teramoto N., Kondo E., Yoshino T., Takahashi K., Yamada M., Tomita N., Miyamoto K., Fujimoto K., Yoshikawa Y. and Akagi T. (1994). HTLV-II non-integrated malignant lymphoma induction in Japanese white rabbits following intravenous inoculation of HTLV-II-infected simian leukocyte cell line (Si-IIA). Jpn. J. Cancer Res. 85, 808-818.
28. Hayashi K., Koirala T., Ino H., Chen H.-L., Ohara N., Teramoto N., Yoshino T., Takahashi K., Yamada N., Nii S., Miyamoto K., Fujimoto K., Yoshikawa Y. and Akagi T. (1995). Malignant lymphoma induction in rabbits by intravenous inoculation of Epstein-Barr-virus-related herpesvirus from HTLV-II-transformed cynomolgus leukocyte cell line (Si-IIA). Int. J. Cancer 63, 872-880.
29. Hayashi K., Chen H.-L., Yanai H., Koirala T.R., Ohara N., Teramoto N., Oka T., Yoshino T., Takahashi K., Miyamoto K., Fujimoto K., Yoshikawa Y. and Akagi T. (1999). Cyno-EBV (EBV-related Herpesvirus from cynomolgus macaques) induces rabbit malignant lymphomas and their tumor cell lines frequently show specific chromosomal abnormalities. Lab. Invest. 79, 823-835.
30. Hayashi K., Ohara N., Teramoto N., Onoda S., Chen H.L., Oka T., Kondo E., Yoshino T., Takahashi K., Yates J. and Akagi T. (2001). An animal model for human EBV-associated hemophagocytic syndrome: Herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits. Am. J. Pathol. 158, 1533-1542.
31. Ino H., Hayashi K., Yanai H., Teramoto N., Koirala T.R., Chen H.-L., Oka T., Yoshino T., Takahashi K. and Akagi T. (1997). Analysis of the genome of an Epstein-Barr-virus (EBV)-related herpesvirus in a cynomolgus monkey cell line (Si-IIA). Acta Med. Okayama 51, 207-212
32. Ito E., Kitazawa J., Arai K., Otomo H., Endo Y., Imashuku S. and Yokoyama M. (2000). Fatal Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with clonal karyotype abnormality. Int. J. Hematol. 71, 263-265.
33. Jenson H.B., Ench Y., Gao S.J., Rice K., Carey D., Kennedy R.C., Arrand J.R. and Mackett M. (2000). Epidemiology of Herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans. J. Infect. Dis. 181, 1462-1466.
34. Johannessen I. and Crawford D.H. (1999). In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Rev. Med. Virol. 9, 63-77.
35. Kawa K. (2000). Epstein-Barr virus - associated diseases in humans. Int. J. Hematol. 71, 108-117.
36. Kieff E. and Rickinson A.B. (2001). Epstein-Barr virus and its replication. In: Fields virology. 4th ed. Knipe D.M. and Howley P.M. (eds). Lippincott-Williams & Wilkins. Philadelphia. pp. 2511-2573.
37. Kikuta H., Sakiyama Y., Matsumoto S., Oh-Ishi T., Nakano T., Nagashima T., Oka T., Hironaka T. and Hirai K. (1993). Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood. 82, 3259-3264.
38. Kikuta H. (1995). Epstein-Barr virus-associated hemophagocytic syndrome. Leuk. Lymphoma 16, 425-429.
39. Koirala T.R., Hayashi K., Chen H.-L., Ino H., Kariya N., Yanai H., Choudhury C.R. and Akagi T. (1997). Malignant lymphoma induction of rabbits with oral spray of Epstein-Barr virus-related herpesvirus from Si-IIA cells (HTLV-II-transformed Cynomolgus cell line): A possible animal model for Epstein-Barr virus infection and subsequent virus-related tumors in humans. Pathol. Int. 47, 442-448.
40. Komano J., Maruo S., Kurozumi K., Oda T and Takada K. (1999). Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J. Virol. 73, 9827-9731
41. Koriyama C., Akiba S., Iriya K., Yamaguti T., Hamada G.S., Itoh T., Eizuru Y., Aikou T., Watanabe S., Tsugane S. and Tokunaga M. (2001). Epstein-Barr virus-associated gastric carcinoma in Japanese Brazilians and non-Japanese Brazilians in Sao Paulo. Jpn J Cancer Res. 92, 911-917
42. Kulwichit W., Edwards R.H., Davenport E.M., Baskar J.F., Godfrey V. and Raab-Traub N. (1998). Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. USA. 95, 11963-11968.
43. Lapin B.A., Timanovskaya V.V. and Yakovleva L.A. (1985). Herpesvirus HVMA: a new representative in the group of the EBV-like B-lymphotropic herpesviruses of primates. Hamatol Bluttransfus. 29, 312-313.
44. Lay J.D., Tsao C.J., Chen J.Y., Kadin M.E. and Su I.J. (1997). Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J. Clin. Invest. 100: 1969-79.
45. Li SL, Biberfeld P, Ernberg I. (1994). DNA of lymphoma-associated herpesvirus (HVMF1) in SIV-infected monkeys (Macaca Fascicularis) shows homologies to EBNA-1, -2 and -5 genes. Int. J. Cancer 59:287-295.
46. Miller G., Shope T., Coope D., Waters L., Pagano J., Bornkamm G.W. and Henle W. (1977). Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: Tumor incidence, histologic spectrum, antibody responses, demonstration of viral DNA, and characterization of viruses. J. Exp. Med. 145, 948-967.
47. Mistrikova J. and Mrmusova M. (1998). Detection of abnormal lymphocytes in the blood of Balb/c mice infected with murine gammaherpesvirus strain 72: the analogy with Epstein-Barr virus infection. Acta Virol. 42, 79-82.
48. Mistrikova J, Raslova H, Mrmusova M, Kudelova M. (2000). A murine gammaherpesvirus. Acta Virol. 44, 211-226.
49. Mittrucker H.W., Muller-Fleckenstein I., Fleckenstein B. and Fleisher B. (1992). CD2-mediated growth of herpes virus saimiri-transformed human T lymphocytes. J. Exp. Med. 176, 909-913.
50. Miyamoto K., Tomita N., Hayashi K. and Akagi T. (1990). Transformation of animal cells with human T-cell leukemia virus type II. Jpn. J. Cancer Res. 81, 720-722.
51. Moghaddam A., Koch J., Annis B. and Wang F. (1998). Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr-virus. J. Virol. 72, 3205-3212
52. Moiser D.E., Gulizia R.J., Baird S.M. and Wilson D.B. (1998). Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335, 256-259.
53. Mroczek E.C., Weisenburger D.D., Grierson H.L., Markin R. and Purtilo D.T. (1987). Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch. Pathol. Lab. Med. 111, 530-535.
54. Niedobitek G., Agathanggelou A., Finerty S., Tierney R., Watkins P., Jones E.L., Morgan A., Young L.S. and Rooney N. (1994). Latent Epstein-Barr-virus infected in cottontop tamarins, a possible model for Epstein-Barr-virus infection in human. Am. J. Pathol. 145, 969-978.
55. Ohara N, Hayashi K, Miyamoto K, Tomita N, Fujiwara K, Kondo E, Takahashi K, Ohtsuki Y, Akagi T (1993). A human T cell line with an abnormal trisomy 2 karyotype established by coculture of peripheral lymphocytes with an HTLV-II-infected simian leukocyte cell line. Acta Pathol. Jpn. 43, 237-243.
56. Ohara N, Hayashi K, Teramoto N, Oka T, Fujimoto K, Yoshikawa Y, Castanos-Velez E, Biberfeld P, Akagi T. (2000). Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey. Intervirology 43, 102-106
57. Ohshima K., Suzumiya J., Kanda M., Kato A. and Kikuchi M. (1998). Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease. Cancer Lett. 122, 43-50.
58. Okano M. and Gross T.G. (1996). Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am. J. Hematol. 53, 111-115.
59. Quintanilla-Martinez L., Kumar S., Fend F., Reyes E, Teruya-Feldstein J, Kingma D.W., Sorbara L., Raffeld M., Strauss S.E. and Jaffe E.S. (2000). Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96, 443-451.
60. Rezikyan S, Kaaya EE, Ekman M, Voevodin AF, Feichtinger H, Putkonen P, Castanos-Velez E, Bieberfeld G, Bieberfeld P (1995). B-cell lymphomagenesis in SIV-immunosuppressed cynomolgus monkeys. Int. J. Cancer 61, 574-579
61. Rickinson A.B. and Kieff E. (1996). Epstein-Barr virus. Fields virology. Fields B.N., Knipe D.M. and Howley P.M.Philadelphia, Lippincott-Raven. pp 2397-2446
62. Rickinson A.B. and Kieff E. (2001). Epstein-Barr virus. Fields virology. Knipe D.M. and Howley P.M. (eds). Philadelphia, Lippincott Williams & Wilkins, 2001, pp 2575-2627.
63. Rivadeneira E.D., Ferrari M.G., Jarrett R.F., Armstrong A.A., Markham P., Birkebak T., Takemoto S., Johnson-Delaney C., Pecon-Slattery J., Clark E.A. and Franchini G. (1999). A novel Epstein-Barr virus-like virus, HV(MNE), in a Macaca nemestrina with mycosis fungoides. Blood 94, 2090-2101.
64. Ruf I.K., Rhyne P.W., Yang C., Cleveland J.L. and Sample J.T. (2000). Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J. Virol. 74, 10223-10228.
65. Sharp P.M., Robertson D.L. and Hahn B.H. (1995). Cross-species transmission and recombination of 'AIDS' viruses. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 349, 41-47.
66. Schatzl H., Tschikobava M., Rose D., Voevodin A., Nitschko H., Sieger E., Bush U., von der Helm K. and Lapin B. (1993). The Sukhumi primate monkey model for viral lymphogenesis: high incidence of lymphomas with presence of STLV-I and EBV-like virus. Leukemia 7 [Suppl 2], 86-92.
67. Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K. (1994). Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 68: 6069-73
68. Smith RD. (1997). Is Epstein-Barr virus a human oncogene or only an innocent bystander? Hum Pathol. 28, 1333-1335.
69. Su I.J., Hsu Y.H., Lin M.T., Cheng A.L., Wang C.H. and Weiss L.M. (1993). Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 72, 2019-2027.
70. Su I.J., Chen R.L., Lin D.T., Lin KS, Chen CC. (1994). Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am. J. Pathol. 144: 1219-1225.
71. Su I.J., Wang C.H., Cheng A.L. and Chen R.L. (1995). Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma. 19, 401-406.
72. Sunil-Chandra N.P., Arno J., Fazakerley J. and Nash A.A. (1994). Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am. J. Pathol. 145, 818-826.
73. Tokunaga M., Uemura Y., Tokudome T., Ishidate T., Masuda H., Okazaki E., Kaneko K., Naoe S., Ito M., Okamura A., Shimada A., Sato E. and Land C.E. (1993). Epstein-Barr virus related gastric cancer in Japan: a molecular patho-epidemiological study. Acta Pathol. Jpn. 43, 574-581.
74. Usherwood E.J., Stewart J.P. and Nash A.A. (1996). Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. J. Virol. 70, 6516-6518.
75. Wang F. (2001). A new animal model for Epstein-Barr virus pathogenesis. In: Epstein-Barr virus and human cancers. Takada K (ed). Springer. Berlin. pp 201-219.
76. Wang F., Rivailler P., Rao P. and Cho Y. (2001). Simian homologues of Epstein-Barr virus. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 29, 356 (1408), 489-497.
77. Weiss LM, Movahed LA, Warnke R. and Sklar J. (1989). Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 320, 502-506.
78. Weiss L.M. and Chang K.L. (1996). Association of the Epstein-Barr virus with hematolymphoid neoplasia. Adv. in Anat. Pathol. 3, 1-15
79. Wilson J.B., Bell J.L. and Levine A.J. (1996). Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15:3117-26.
80. Wilson J.B. (1997). Transgenic mouse models of disease and Epstein-Barr virus. Epstein-Barr virus report 4, 63-72.
81. Wutzler P., Meerbach A., Farber I., Wolf H. and Scheibner K. (1995). Malignant lymphomas induced by an Epstein-Barr virus-related herpesvirus from Macaca arctoides- a rabbit model. Arch. Virol. 140, 1979-1995.
82. Yamashita S., Murakami C., Izumi Y., Sawada H., Yamazaki Y., Yokota T.A., Matsumoto N. and Matsukura S. (1998). Severe chronic active Epstein-Barr virus infection accompanied by virus-associated hemophagocytic syndrome, cerebellar ataxia and encephalitis. Psychiatry Clin. Neurosci. 52, 449-452.
83. Yates J.L., Camiolo S.M., Ali S. and Ying A. (1996). Comparison of the EBNA1 proteins of Epstein-Barr virus and Herpesvirus papio in sequence and function. Virology 222, 1-13.